4th Annual Gene Therapy for Neurological Disorders Summit Europe

Memo

Returning as the pinnacle event in the industry, the 4th Annual Gene Therapy for Neurological Disorders Summit Europe (https://ter.li/t7u6xp) (6-8 June 2023, Amsterdam) enables you to bring your gene therapy to patients in Europe. This year's content takes a greater focus on:- Innovation in preclinical models and vector technology- Showcasing novel approaches to improve delivery in a safe manner- Optimizing administration route to reduce the patient- Understanding what needs to be done to crack the European marketDownload the agenda to find out more - https://ter.li/gm4e9zCovering both neurodevelopmental and neurodegenerative disorders, join 80+ of your peers in Amsterdam this June. We'll be welcoming those leading biopharma and academia, working in preclinical, clinical, and market access to help get safer, more efficacious gene therapies for neurological disorders to market in Europe.As the gene therapy community gets a second wind and as the clinical promise in neurology begins to be realised, now is the time to get your hands on the latest innovations in this field to bring safe, efficacious, and commercially successful products to market in Europe.Register to attend - https://ter.li/lvew8jBrochure: https://go.evvnt.com/1539777-2?pid=5569 Date and Time: On Tuesday June 06, 2023 at 8:00 am to Thursday June 08, 2023 at 5:00 pmVenue details: Steigenberger Airport Hotel, 951 Stationsplein Zuid-West, Schiphol, Noord-Holland, 1117 CE, NetherlandsPrices:Full Access Pass (Conference + Workshop Day): EUR 3897.00,Conference Only: EUR 2799.00Speakers: Adriana Galvan, Emory University School Of Medicine, Ahad Rahim, University College London, Alison Shottek, Modalis Therapeutics Corp., Ambreen Sayed-Zahid, Voyager Therapeutics, Anindya Sen, Eli Lilly and Co., Boaz Levi, Allen Institute, Brian Bigger, University of Manchester, Jennifer Johnston, NysnoBio, Jose L. Lanciego, University of Navarra, Laura Campbell, Orchard Therapeutics, Maria Grazia Biferi, Spark Therapeutics, Michael Linden, Handl Therapeutics, Nathalie Cartier Lacave, AskBio, Oswald Bentinck, Rocket Pharmaceuticals, Pavlina Konstantinova, VectorY, Rainel Sanchez de la Rosa, Astellas Gene Therapies, Rodolphe Clerval, Coave Therapeutics, Stephane Palfi, Portail Assistance Publique-Hopitaux de Paris, Thomas Bols, PTC Therapeutics, William Gray, Cardiff University